文献速递胸部病理

良性肺病变患者早期COVID-19肺炎的肺部病理

Pulmonary pathology of early-phase COVID-19 pneumonia in a patient with a benign lung lesion.
PubMed 文献 · Histopathology · 2020-09-15

本文分析一名55岁女性早期SARS-CoV-2感染者的肺组织病理,该患者因良性肺结节行右肺下叶切除术,术前经实时逆转录聚合酶链反应和RNA原位杂交确诊感染。病理以渗出性炎症为特征,近脏层胸膜单核细胞和淋巴细胞渗出更重,未见典型SARS的纤维素性渗出和透明膜形成。

要点

  • 早期COVID-19肺炎以渗出性炎症为主,渗出程度近脏层胸膜更重
  • 可见血管周围炎性浸润、肺泡内多核巨细胞、肺泡上皮增生及胞质内病毒样包涵体
  • 未见SARS肺炎典型的纤维素性渗出和透明膜形成

核心结论

  • 早期SARS-CoV-2感染的肺部病理以渗出性炎症为特征,提示免疫功能障碍参与COVID-19肺炎发病机制。

研究设计与样本

  • 分析一名55岁女性早期SARS-CoV-2感染者的肺组织病理,该患者因良性肺结节行右肺下叶切除术。

主要发现

  • COVID-19肺炎表现为渗出性炎症,越靠近脏层胸膜单核细胞和淋巴细胞渗出越重。
  • 可见血管周围炎性浸润、肺泡内多核巨细胞、肺泡上皮增生和胞质内病毒样包涵体。
  • 未见SARS肺炎典型的纤维素性渗出和透明膜形成。
  • 免疫组化显示肺组织内CD4+辅助T淋巴细胞和CD163+ M2巨噬细胞异常积聚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: An ongoing outbreak of 2019 novel coronavirus (CoV) disease (COVID-19), caused by severe acute respiratory syndrome (SARS) CoV-2, has been spreading in multiple countries. One of the reasons for the rapid spread is that the virus can be transmitted from infected individuals without symptoms. Revealing the pathological features of early-phase COVID-19 pneumonia is important for understanding of its pathogenesis. The aim of this study was to explore the pulmonary pathology of early-phase COVID-19 pneumonia in a patient with a benign lung lesion. METHODS AND RESULTS: We analysed the pathological changes in lung tissue from a 55-year-old female patient with early-phase SARS-CoV-2 infection. In this case, right lower lobectomy was performed for a benign pulmonary nodule. Detailed clinical, laboratory and radiological data were also examined. This patient was confirmed to have preoperative SARS-CoV-2 infection by the use of real-time reverse transcription polymerase chain reaction and RNA in-situ hybridisation on surgically removed lung tissues. Histologically, COVID-19 pneumonia was characterised by exudative inflammation. The closer to the visceral pleura, the more severe the exudation of monocytes and lymphocytes. Perivascular inflammatory infiltration, intra-alveolar multinucleated giant cells, pneumocyte hyperplasia and intracytoplasmic viral-like inclusion bodies were seen. However, fibrinous exudate and hyaline membrane formation, which were typical pulmonary features of SARS pneumonia, were not evident in this case. Immunohistochemical staining results showed an abnormal accumulation of CD4+ helper T lymphocytes and CD163+ M2 macrophages in the lung tissue. CONCLUSION: The results highlighted the pulmonary pathological changes of early-phase SARS-CoV-2 infection, and suggested a role of immune dysfunction in the pathogenesis of COVID-19 pneumonia.

来源:Histopathology,查看原文。版权归原作者所有。

引用

  1. Zeng Z, Xu L, Xie XY, et al. Pulmonary pathology of early-phase COVID-19 pneumonia in a patient with a benign lung lesion. Histopathology. 2020. PMID: 32374419. doi:10.1111/his.14138

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。